Gut Registry

entity · release 2026-09-20

Limosilactobacillus reuteri DSM 17938

Structured fields rendered from the release dataset. Unknown values retain a reason; price is outside GIS.

Across the corpus

How this organism is actually sold

Printed CFU per serving
100,000,000 – 100,000,000; median 100,000,000. Measured on the 2 of 3 published products carrying it whose latest published label prints a figure for it; the rest print a blend total or no quantity, and earlier label versions in the table below may print other figures. 0 row(s) print a CFU below 1 000 and are excluded as a label or parsing artefact.
Forms
Liquid: 3 · counted across the 3 of 3 published products whose label states a form
Brands carrying it
biogaia (1) · gerber (1) · gerber-good-start (1)
Published product pages
3

Products

Published products carrying this organism

ProductPrinted CFUPrinted doseCost per dayFormGut Index Score
Gerber Soothe Probiotic Colic Drops100,000,000not printednot observedLiquid88.75
Gerber Good Start Soothe Vitamin D & Probiotic Drops100,000,000not printednot observedLiquid88.75
BioGaia Prodentis Probiotic Dropsnot printednot printednot observedLiquid61.75
Containing labels7
Evidence amount1.00
Direction balanceThe direction of the study results has not been extracted.

Matched PubMed records

126 records (retracted records excluded; 0 retracted records match the query separately). PubMed query

Matched records include trials of multi-ingredient products; this is not a count of trials of this entity alone.

  1. 2026 · Nutritional Stunting Is Linked to Reduced Oral Microbiome Stability and Reconfigured Microbial Networks in Children: A Pilot Intervention Study.
  2. 2026 · Long-Term Efficacy of Limosilactobacillus reuteri DSM17938 in the Prevention of Functional Abdominal Pain Disorders.
  3. 2026 · Interpheron type II signature in mucosal swabs of patient with infantile colic treated with Limosilactobacillus reuteri (L. reuteri) LMG P-27481.
  4. 2025 · A young child formula with Limosilactobacillus reuteri and GOS modulates gut microbiome and enhances bone and muscle development: a randomized trial.
  5. 2025 · Safety and tolerance of infant formulas containing probiotics: a multicenter, randomised, controlled trial in healthy term infants.
  6. 2025 · Efficacy of Lactobacillus reuteri DSM 17938 in Thai children with acute gastroenteritis and normal or mild dehydration in an outpatient setting: a randomized controlled trial.
  7. 2025 · Probiotics Enhance Bone Density and Reduce Inflammation Postalveolar Surgery.
  8. 2025 · Effect of Limosilactobacillus reuteri DSM17938 to prevent antibiotic-associated diarrhea in children: prospective, multi-center, randomized, placebo-controlled clinical trial (PEARL Study).
  9. 2025 · The Probiotic Effects of Lactobacillus brevis CD2 on Caries Related Variables of Dental Plaque Biofilm.
  10. 2025 · Lactobacillus reuteri protectis DSM 17938 at high doses versus placebo in children with acute gastroenteritis in a Pediatric Emergency Department.

and 116 more

ClinicalTrials.gov

93 interventional studies. ClinicalTrials.gov query

This species has 22 tracked designations; this one appears on 7 labels (median 4).

Species and related strains

Limosilactobacillus reuteri

Axis 1 · inverted

Containing label versions

Showing 7 of 7 rows, ordered by Gut Index Score descending, then DSLD label ID. Download full CSV · Download full JSON.

BrandProductDSLDGut Index ScoreStrain namedPer-organism quantityPotency basisVersions
GerberSoothe Probiotic Colic Drops24011388.75true100,000,000 CFUnot stated1
Gerber Good StartSoothe Vitamin D & Probiotic Drops27727188.75true100,000,000 CFUnot stated1
BioGaiaProdentis Apple Flavor31101061.75truenot printed for this organismnot stated1
BioGaiaProdentis Probiotic Drops31101161.75truenot printed for this organismnot stated1
BioGaiaProdentis Kids Apple Flavored31101261.75truenot printed for this organismnot stated1
BioGaiaProdentis Mint Flavor31102361.75truenot printed for this organismnot stated1
BioGaiaGastrus311007Not available in this release.trueundefined: light snapshotnot stated1

Axis 2

Studiedness

Evidence amount
1.00
Direction balance
The direction of the study results has not been extracted.
PMID records loaded
126
Records after title/year deduplication
126

Axis 3

Measurement integrity

Not a measurement product, so this axis does not apply.

Axis 4

Reddit mention panel

0 observed mentions; no aggregate panel matched this entity.

Elsewhere in this release

Related pages

Findings computed over the whole corpus: Strain naming census · Label designation changes · Strain dose match · Stability literature gaps

Tools: DSLD product check · Unit value calculator

Citation

Cite this page

Ivitskiy, I. (2026). Limosilactobacillus reuteri DSM 17938. Gut Registry, release 2026-09-20. Elanvale Ltd. https://gutregistry.com/s/limosilactobacillus-reuteri-dsm-17938/

The underlying tables are published under CC BY 4.0: this page as CSV · as JSON · full release and data dictionary. Cell-level provenance names the source record and its observation date.

Citable atoms

Release claims

  1. Limosilactobacillus reuteri DSM 17938 appears on 7 of 13,330 labels in the NIH DSLD snapshot (Sep 2026), from 3 brands; tied with 21 designations by distinct label count.

    7 / 13330 observed label versions · NIH DSLD snapshot Sep 2026 · entity.prevalence · checked 2026-09-20T00:00:00Z · snapshot b7633f732437

  2. 2 of 7 containing labels in the NIH DSLD snapshot (Sep 2026) print a quantity for Limosilactobacillus reuteri DSM 17938 (28.6%); 1 light records have quantities unavailable.

    2 / 7 containing labels · NIH DSLD snapshot Sep 2026 · entity.quantity · checked 2026-09-20T00:00:00Z · snapshot b7633f732437

  3. 126 PubMed records indexed as human randomized controlled trials match the published query (as of 2026-09-15). 126 records (retracted records excluded; 0 retracted records match the query separately).

    Published PubMed query

    126 / 126 loaded PMID records · NIH DSLD snapshot Sep 2026 · entity.evidence · checked 2026-09-20T00:00:00Z · snapshot b7633f732437

  4. 93 interventional studies on ClinicalTrials.gov match the published query.

    Published ClinicalTrials.gov query

    93 / Not available in this release. interventional registry studies · NIH DSLD snapshot Sep 2026 · entity.registered_trials · checked 2026-09-20T00:00:00Z · snapshot b7633f732437

  5. 1 of 7 SKUs containing Limosilactobacillus reuteri DSM 17938 have a numeric price observation (14.3%) in the release accompanying the NIH DSLD snapshot Sep 2026.

    1 / 7 containing SKUs · NIH DSLD snapshot Sep 2026 · entity.price · checked 2026-09-20T00:00:00Z · snapshot b7633f732437

Back to the release hub